Quantoom Bioservices: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Quantoom Bioservices
Largest movements
- Cash -€27,286
down €27,286 (-45.9%), from €59,454 to €32,168
mainly Other debts (-€56,000) and Trade debts (-€45,655)
- Receivables within one year +€20,104
up €20,104 (+297.3%), from €6,763 to €26,867
of which Other amounts receivable: +€15,788
- Profit (loss) carried forward +€94,473
up €94,473 (+91.3%), from -€103,505 to -€9,032
- Other debts -€56,000
no longer reported in 2023 (was €56,000)
- Trade debts -€45,655
down €45,655 (-87.4%), from €52,222 to €6,567
- Gross operating margin +€68,770
up €68,770 (+66.6%), from -€103,261 to -€34,491
From the 2022 result to the 2023 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2022 and 2023 balance sheets and the 2023 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2022 | 2023 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €66,217 | €59,035 | -€7,182 | -10.8% |
| Current assets | 29/58 | €66,217 | €59,035 | -€7,182 | -10.8% |
| Amounts receivable within one year | 40/41 | €6,763 | €26,867 | +€20,104 | +297.3% |
| Trade receivables | 40 | - | €4,316 | +€4,316 | |
| Other amounts receivable | 41 | €6,763 | €22,551 | +€15,788 | +233.4% |
| Cash at bank and in hand | 54/58 | €59,454 | €32,168 | -€27,286 | -45.9% |
| Total equity and liabilities | 10/49 | €66,217 | €59,035 | -€7,182 | -10.8% |
| Equity | 10/15 | -€42,005 | €52,468 | +€94,473 | |
| Contributions | 10/11 | €61,500 | €61,500 | = | 0.0% |
| Capital | 10 | €61,500 | €61,500 | = | 0.0% |
| Issued capital | 100 | €61,500 | €61,500 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€103,505 | -€9,032 | +€94,473 | +91.3% |
| Amounts payable | 17/49 | €108,222 | €6,567 | -€101,655 | -93.9% |
| Amounts payable within one year | 42/48 | €108,222 | €6,567 | -€101,655 | -93.9% |
| Trade debts | 44 | €52,222 | €6,567 | -€45,655 | -87.4% |
| Suppliers | 440/4 | €52,222 | €6,567 | -€45,655 | -87.4% |
| Other amounts payable | 47/48 | €56,000 | - | -€56,000 | |
| Other operating charges | 640/8 | €100 | €483 | +€383 | +382.8% |
| Non-recurring operating charges | 66A | - | €50 | +€50 | |
| Gross operating margin | 9900 | -€103,261 | -€34,491 | +€68,770 | +66.6% |
| Operating profit (loss) | 9901 | -€103,361 | -€35,024 | +€68,337 | +66.1% |
| Financial charges | 65/66B | €144 | €504 | +€360 | +249.9% |
| Recurring financial charges | 65 | €144 | €504 | +€360 | +249.9% |
| Profit (loss) for the period before taxes | 9903 | -€103,505 | -€35,527 | +€67,978 | +65.7% |
| Profit (loss) for the period | 9904 | -€103,505 | -€35,527 | +€67,978 | +65.7% |
| Profit (loss) for the period to be appropriated | 9905 | -€103,505 | -€35,527 | +€67,978 | +65.7% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2022 and 31 December 2023. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 6 October 2026 via checked.be.